REAMPLA Trademark

Trademark Overview

On Monday, February 6, 2006, a trademark application was filed for REAMPLA with the United States Patent and Trademark Office. The USPTO has given the REAMPLA trademark a serial number of 78808402. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 20, 2015. This trademark is owned by Pfizer Inc.. The REAMPLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
reampla

General Information

Serial Number78808402
Word MarkREAMPLA
Filing DateMonday, February 6, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 20, 2015
Registration Number3607670
Registration DateTuesday, April 14, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 20, 2015
Primary Code005
First Use Anywhere DateThursday, December 11, 2008
First Use In Commerce DateThursday, December 11, 2008

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, November 20, 2015CANCELLED SEC. 8 (6-YR)
Tuesday, April 14, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, March 10, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, March 10, 2009ASSIGNED TO LIE
Tuesday, March 10, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 3, 2009STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 26, 2009USE AMENDMENT FILED
Thursday, February 26, 2009TEAS STATEMENT OF USE RECEIVED
Wednesday, January 28, 2009EXTENSION 4 GRANTED
Wednesday, January 28, 2009EXTENSION 4 FILED
Wednesday, January 28, 2009TEAS EXTENSION RECEIVED
Friday, August 8, 2008EXTENSION 3 GRANTED
Tuesday, July 29, 2008EXTENSION 3 FILED
Friday, August 8, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 29, 2008TEAS EXTENSION RECEIVED
Tuesday, February 19, 2008EXTENSION 2 GRANTED
Tuesday, January 29, 2008EXTENSION 2 FILED
Tuesday, January 29, 2008TEAS EXTENSION RECEIVED
Thursday, August 30, 2007EXTENSION 1 GRANTED
Thursday, June 7, 2007EXTENSION 1 FILED
Thursday, June 7, 2007TEAS EXTENSION RECEIVED
Wednesday, February 14, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 30, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 7, 2006PUBLISHED FOR OPPOSITION
Wednesday, October 18, 2006NOTICE OF PUBLICATION
Friday, September 22, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 28, 2006ASSIGNED TO LIE
Friday, July 21, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 20, 2006ASSIGNED TO EXAMINER
Monday, February 13, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

reampla cancer treatment preparations pharmaceutical